PROCYSBI

Amgen Canada Inc🇨🇦 Health Canada

Approval Id: 6915a4f4e69880df
Drug Approval Canada Name: PROCYSBI
Product Name: PROCYSBI
Status: Marketed
Status Date: 2025-04-17
Original Market Date: 2017-10-17
Din: 02464705
Drug Class: Human
Dosage Form: Capsule (Delayed Release)
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 92:92.00
Atc Original: A16AA04 MERCAPTAMINE
Atc Name: a 16 aa 04
Aig Number: 0159170001
Company Name: Amgen Canada Inc
Company Address: 300, 6775 Financial Drive, Mississauga, Ontario, Canada, L5N 0A4

CYSTEAMINE (CYSTEAMINE BITARTRATE)

25 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

6915a4f4e69880df

Type

Standard